Publications by authors named "Vincent Cottin"

100Publications

Characteristics and long-term outcomes of pulmonary veno-occlusive disease induced by Mitomycin-C.

Chest 2020 Sep 23. Epub 2020 Sep 23.

INSERM UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies», Hôpital Marie Lannelongue, Le Plessis-Robinson, France; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; University of Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2020.09.238DOI Listing
September 2020

Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study.

Respir Med 2020 Oct 9;172:106146. Epub 2020 Sep 9.

Department of Pneumology and Respiratory Functional Exploration, University Hospital of Tours, Tours, France; INSERM U-1100, Faculty of Medicine of Tours, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2020.106146DOI Listing
October 2020

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS® study).

Eur Respir J 2020 Sep 17. Epub 2020 Sep 17.

Department of Respiratory Medicine, National Coordinating Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, University Hospital of Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02718-2020DOI Listing
September 2020

Hemodynamic response to treatment and outcome in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in systemic sclerosis.

Arthritis Rheumatol 2020 Sep 6. Epub 2020 Sep 6.

Hospices Civils de Lyon, Service de Pneumologie, Centre de référence national des maladies pulmonaires rares, Centre de compétence de l'hypertension pulmonaire, Hôpital Louis Pradel ; UMR754, Université Claude Bernard Lyon 1, member of OrphaLung, RespiFil, ERN-LUNG, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.41512DOI Listing
September 2020

Spectrum of Fibrotic Lung Diseases.

N Engl J Med 2020 09;383(10):958-968

From the Center for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands (M.W.); and the Department of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, and Claude Bernard University - both in Lyon, France (V.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMra2005230DOI Listing
September 2020

New therapeutic strategies in lung vasculitis.

Curr Opin Pulm Med 2020 Sep;26(5):496-506

Department of Respiratory Medicine, National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000693DOI Listing
September 2020

Idiopathic non-necrotizing eosinophilic vasculitis limited to the lung: Part of a complex spectrum.

J Allergy Clin Immunol Pract 2020 Jul - Aug;8(7):2454-2455

Department of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France; Université Claude Bernard Lyon 1, UMR754, Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2020.04.027DOI Listing
February 2020

Diagnostic Features in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review.

Ann Am Thorac Soc 2020 10;17(10):1333-1336

University of British Columbia Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/AnnalsATS.202002-122RLDOI Listing
October 2020

Desquamative interstitial pneumonia: still orphan and not always benign.

Authors:
Vincent Cottin

Eur Respir Rev 2020 Jun 23;29(156). Epub 2020 Jun 23.

National Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, UMR 754, Claude Bernard University Lyon 1, Lyon, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/16000617.0183-2020DOI Listing
June 2020

SARCOIDOSIS DIAGNOSED IN THE ELDERLY: A CASE CONTROL STUDY.

QJM 2020 Jun 22. Epub 2020 Jun 22.

Department of Internal Medicine, University Hospital Lyon Croix-Rousse, Claude Bernard University - Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/qjmed/hcaa171DOI Listing
June 2020

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.

Neurology 2020 07 2;95(1):e70-e78. Epub 2020 Jun 2.

From the Departments of Clinical Immunology and Internal Medicine (Y.A., S.T., G.L., B.H., N.C., K.M., O.B.), Immunobiology (M.M.), and Biostatistics, Public Health, and Medical Information (B.G.), Pitié-Salpêtrière Hospital, APHP, Sorbonne Universities; Myology Research Centre (Y.A., O.B.), INSERM, UMRS 974, Paris; Department of Pneumology (Y.U., H.N.), APHP, Avicenne Hospital, INSERM U1272, Université Sorbonne Paris Nord, Bobigny; Department of Internal Medicine (L.G., A. Marquet), Lyon Sud Hospital, Lyon Sud University, Paris; Reference Centre for Rare Autoimmune Diseases (A. Meyer) and Medical Intensive Care Unit, Hautepierre Hospital (V. Castelain), Hôpitaux Universitaires de Strasbourg, Strasbourg University; Division of Pneumology (R.B.), Bichat Hospital, AP-HP, Paris-Diderot University, Paris; Department of Pneumology (F.G., P.P.), Centre Hospitalier Universitaire, Angers University; Department of Internal Medicine Infectieuses (C.D.), CHU de Martinique, Fort de France; Departments of Internal Medicine and Clinical Immunology (S.A.) and Internal Medicine and Systemic Diseases (H.D.), François-Mitterrand University Hospital, University of Bourgogne-Franche-Comté, Dijon; Internal Medicine Department (B.T., A.B.), Cochin Hospital, AP-HP, René Descartes University, Paris; Department of Internal Medicine (C.G., N.L.), Henri Mondor Hospital, Paris Est Créteil University, Créteil, France; Department of Neurology (N.V.), Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Internal Medicine (E.D.), Hôpital Bretonneau Tours, Tours University; Internal Medicine Department (A.S.), Hôpital Robert-Debré, Reims University; Departments of Rheumatology (T.M.) and Internal Medicine (L.D.S.M.), Bretagne Occidentale University, Centre Hospitalo-Universitaire de Brest; Department of Internal Medicine (S.H.), CHU de Besançon; Department of Internal Medicine (C.B.-D.), Centre Hospitalier Général de Niort; Department of Internal Medicine (N.T.), Nice University, CHU Nice; Department of Internal Medicine (P.C.), Institut Mutualiste Montsouris, Paris; Department of Internal Medicine (M.G.), Jean Verdier Hospital, Paris Seine-Saint-Denis University, Bondy; Department of Internal Medicine (A. Mekinian), Saint Antoine Hospital, APHP, Sorbonne Universities, Paris; Department of Pneumology CHU (J.C.M.), Poitiers University; Department of Pneumology (A.T.), Hôpital Saint-Louis, APHP, Sorbonne Paris Cité, University Paris-Diderot, Paris; Department of Respiratory Medicine (V. Cottin), National Reference Center for Rare Pulmonary Diseases, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon University; Department of Pneumology (D.I.-B.), European George Pompidou Hospital, APHP, Paris V University; Department of Pneumology (S.P.-H.), Sainte-Camille Hospital, Bry-sur-Marne; Department of Pneumology (C.B.), Foch Hospital, Saint Quentin en Yveline University, Suresnes; and Department of Immunology (N.F.), Lyon-Sud Hospital, Hospices Civils-de-Lyon, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000009727DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371381PMC
July 2020

Diagnostic approach of fibrosing interstitial lung diseases of unknown origin.

Presse Med 2020 Jun 11;49(2):104021. Epub 2020 May 11.

Pulmonology Department, Hospital Universitario de la Princesa, Madrid, Spain; Universidad Autonoma de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2020.104021DOI Listing
June 2020

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension.

Eur Respir J 2020 Sep 3;56(3). Epub 2020 Sep 3.

APHP, National Reference Centre for Pulmonary Hypertension, Dept of Respiratory and Intensive Care Medicine, Bicêtre Hospital, University Paris-Sud - University Paris Saclay, INSERM UMR_S999, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00673-2020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469971PMC
September 2020

Diurnal variation in forced vital capacity in patients with fibrotic interstitial lung disease using home spirometry.

ERJ Open Res 2020 Jan 6;6(1). Epub 2020 Apr 6.

Dept of Respiratory Medicine, Erasmus Medical Center, University Hospital Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/23120541.00054-2020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132034PMC
January 2020

Patients' and Healthcare Professionals' Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey.

Pulm Ther 2020 Jun 19;6(1):93-105. Epub 2020 Mar 19.

Department of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s41030-020-00111-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229113PMC
June 2020

Presenting the Board of Respiration: Vincent Cottin.

Authors:
Vincent Cottin

Respiration 2020;99(3):206. Epub 2020 Mar 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000506845DOI Listing
March 2020

Survey of Physician's Knowledge, Attitudes, and Practices Regarding Idiopathic Pulmonary Fibrosis in Turkey.

Turk Thorac J 2020 Jan 1;21(1):44-48. Epub 2020 Jan 1.

Department of Pulmonary Diseases, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5152/TurkThoracJ.2019.180181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020893PMC
January 2020

Lung-limited or lung-dominant variant of eosinophilic granulomatosis with polyangiitis.

J Allergy Clin Immunol Pract 2020 Jun 2;8(6):2092-2095. Epub 2020 Mar 2.

Department of Respiratory Medicine, National Coordinating Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France; UMR754, Claude Bernard University Lyon 1, Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2020.01.058DOI Listing
June 2020

Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult.

Eur Respir J 2020 04 9;55(4). Epub 2020 Apr 9.

Dept of Pathology, Groupement Hospitalier Est, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01952-2019DOI Listing
April 2020

Interstitial Pneumonia With Autoimmune Features (IPAF).

Front Med (Lausanne) 2019 27;6:209. Epub 2019 Sep 27.

Department of Respiratory Medicine, National Reference Center for Rare Pulmonary Diseases, Hospices Civils de Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmed.2019.00209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798044PMC
September 2019

Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases.

Authors:
Vincent Cottin

Eur Respir Rev 2019 09 1;28(153). Epub 2019 Oct 1.

National Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, UMR754, Claude Bernard University Lyon 1, Lyon, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/16000617.0109-2019DOI Listing
September 2019

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.

Lancet Respir Med 2020 02 29;8(2):147-157. Epub 2019 Sep 29.

National Reference Coordinating Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Lyon, France; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30341-8DOI Listing
February 2020

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

N Engl J Med 2019 10 29;381(18):1718-1727. Epub 2019 Sep 29.

From the Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor (K.R.F.); the National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust (A.U.W.), the National Heart and Lung Institute, Imperial College (A.U.W., A.D., S.L.F.W.), and the Department of Radiology, Royal Brompton and Harefield NHS Foundation Trust (A.D.) - all in London; the National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Unité Mixte de Recherche 754, Lyon, France (V.C.); the Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Japan (Y.I.); Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); McMaster University and St. Joseph's Healthcare, Hamilton, ON, Canada (M.K.); Boehringer Ingelheim International, Ingelheim am Rhein (K.T., S.S., E.C.-B., M.Q., T.H.), the Department of Sports Medicine, University of Tübingen, Tübingen (K.T.), and Boehringer Ingelheim Pharma, Biberach (B.R., R.-G.G.) - all in Germany; Boehringer Ingelheim, Brussels (C.C.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (R.S.-H.); and the Department of Medicine, National Jewish Health, Denver (K.K.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1908681DOI Listing
October 2019

Assessment of T-cell polarization on the basis of surface marker expression: Diagnosis and potential therapeutic implications in lymphocytic variant hypereosinophilic syndrome.

J Allergy Clin Immunol Pract 2020 Mar 13;8(3):1110-1114.e2. Epub 2019 Sep 13.

Institut d'Immunologie, CHU de Lille, Lille, France; Univ. Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France; Département de Médecine Interne, CHU de Lille, Lille, France; Centre de Référence National des Syndromes Hyperéosinophiliques (CEREO), Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2019.08.049DOI Listing
March 2020

Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanib.

Respir Med 2019 09 6;156:20-25. Epub 2019 Aug 6.

National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2019.08.002DOI Listing
September 2019

Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.

Curr Med Res Opin 2019 11 2;35(11):2015-2024. Epub 2019 Aug 2.

Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Claude Bernard University Lyon 1 , Lyon , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2019.1647040DOI Listing
November 2019

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.

Lancet Respir Med 2019 09 17;7(9):771-779. Epub 2019 Jul 17.

National Institute for Health Research Respiratory Biomedical Research Centre, City Campus, Nottingham University Hospital, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30255-3DOI Listing
September 2019

Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France.

J Mark Access Health Policy 2019 24;7(1):1626171. Epub 2019 Jun 24.

Pulmonology Department, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University Claude Bernard Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/20016689.2019.1626171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598518PMC
June 2019

Digital Lung Auscultation: Will Early Diagnosis of Fibrotic Interstitial Lung Disease Become a Reality?

Am J Respir Crit Care Med 2019 07;200(2):261-263

1 Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201902-0306LEDOI Listing
July 2019

Lung Diseases in Inflammatory Myopathies.

Semin Respir Crit Care Med 2019 04 28;40(2):255-270. Epub 2019 May 28.

National Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, UMR754, Claude Bernard University Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1685187
Publisher Site
http://dx.doi.org/10.1055/s-0039-1685187DOI Listing
April 2019

The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis.

Eur Respir J 2019 05 23;53(5). Epub 2019 May 23.

Reference Centre for Rare Pulmonary Diseases, Université Paris Diderot, Inserm U1152, Laboratoire d'Excellence Inflamex, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie A, Département Hospitalo-Universitaire FIRE, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00539-2019DOI Listing
May 2019

Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis.

Chest 2019 10 29;156(4):706-714. Epub 2019 Apr 29.

Department of Respiratory Medicine, Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Claude Bernard University Lyon 1, UMR754, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2019.04.015DOI Listing
October 2019

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).

BMC Pulm Med 2019 Apr 11;19(1):75. Epub 2019 Apr 11.

Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Avicenne, Service de pneumologie, Site constitutif du centre de référence des maladies pulmonaires rares OrphaLung, EA2363, Université Paris, 13, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12890-019-0830-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458697PMC
April 2019

A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT.

Respiration 2019;98(1):19-28. Epub 2019 Apr 9.

Pulmonology Department, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University Claude Bernard Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000496735DOI Listing
September 2020

Cancer incidence in patients with pre-capillary pulmonary hypertension.

J Heart Lung Transplant 2019 07 15;38(7):778-780. Epub 2019 Mar 15.

CHU de St-Etienne, Service de Médecine Vasculaire et Thérapeutique, Saint-Etienne, France; INSERM, UMR1059, Equipe Dysfonction Vasculaire et Hémostase, Université Jean-Monnet, Saint-Etienne, France; INSERM, CIC-1408, CHU Saint-Etienne, Saint-Etienne, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healun.2019.03.007DOI Listing
July 2019

Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies.

Eur Respir J 2019 03 18;53(3). Epub 2019 Mar 18.

Respiratory Diseases Dept, National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Claude Bernard Lyon 1 University, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00283-2019DOI Listing
March 2019

Pulmonary fibrosis: "idiopathic" is not "cryptogenic".

Authors:
Vincent Cottin

Eur Respir J 2019 03 18;53(3). Epub 2019 Mar 18.

Louis Pradel Hospital, Claude Bernard University Lyon 1, National Reference Center for Rare Pulmonary Diseases, Lyon Cedex, Lyon, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02314-2018DOI Listing
March 2019

Pulmonary alveolar proteinosis.

Nat Rev Dis Primers 2019 03 7;5(1):16. Epub 2019 Mar 7.

Department of Medicine, St. Vincent's University Hospital and University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41572-019-0066-3DOI Listing
March 2019

Fibrosing interstitial lung diseases: knowns and unknowns.

Eur Respir Rev 2019 Mar 27;28(151). Epub 2019 Feb 27.

Division of Pulmonary and Critical Care Medicine, San Giuseppe Hospital MultiMedica IRCCS, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/16000617.0100-2018DOI Listing
March 2019

Lung function outcomes in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.

Respir Med 2019 01 19;146:42-48. Epub 2018 Nov 19.

National Institute for Health Research Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust, and National Heart and Lung Institute, Imperial College London, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09546111183037
Publisher Site
http://dx.doi.org/10.1016/j.rmed.2018.11.012DOI Listing
January 2019

Interstitial lung disease associated with systemic sclerosis (SSc-ILD).

Respir Res 2019 Jan 18;20(1):13. Epub 2019 Jan 18.

National Jewish Health, 1400 Jackson Street, Denver, CO, 80206, USA.

View Article

Download full-text PDF

Source
https://respiratory-research.biomedcentral.com/articles/10.1
Publisher Site
http://dx.doi.org/10.1186/s12931-019-0980-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339436PMC
January 2019

Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.

Autoimmun Rev 2019 Feb 17;18(2):113-122. Epub 2018 Dec 17.

Department of Internal and Vascular Medicine, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite F-69310, France; Department of Internal and Vascular Medicine, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon F-69003, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2018.07.013DOI Listing
February 2019

Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end.

Eur Respir J 2018 12 13;52(6). Epub 2018 Dec 13.

National Reference Center for Rare Pulmonary Disease, Louis Pradel Hospital; UMR754, Claude Bernard University, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02111-2018DOI Listing
December 2018

Air travel and incidence of pneumothorax in lymphangioleiomyomatosis.

Orphanet J Rare Dis 2018 12 13;13(1):222. Epub 2018 Dec 13.

Service de pneumologie, Centre hospitalier universitaire vaudois, PMU BU44.07, Rue du Bugnon 44, 1011, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-018-0964-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293523PMC
December 2018

Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension.

ERJ Open Res 2018 Oct 28;4(4). Epub 2018 Nov 28.

Competence Center for Severe Pulmonary Hypertension, Reference Center for Rare Pulmonary Diseases, Dept of Respiratory Medicine, Hospices Civils de Lyon, Louis Pradel Hospital, Lyon, France.

View Article

Download full-text PDF

Source
http://openres.ersjournals.com/lookup/doi/10.1183/23120541.0
Publisher Site
http://dx.doi.org/10.1183/23120541.00100-2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258090PMC
October 2018

Alveolar Hemorrhage in Vasculitis (Primary and Secondary).

Semin Respir Crit Care Med 2018 08 7;39(4):482-493. Epub 2018 Nov 7.

Department of Respiratory Medicine, Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1668533DOI Listing
August 2018

12q13.12q13.13 microdeletion encompassing ACVRL1 and SCN8A genes: Clinical report of a new contiguous gene syndrome.

Eur J Med Genet 2019 Nov 30;62(11):103565. Epub 2018 Oct 30.

Hospices Civils de Lyon, Genetic Department and National HHT Reference Center, Femme-Mère-Enfants Hospital, Bron, F-69677, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S17697212183055
Publisher Site
http://dx.doi.org/10.1016/j.ejmg.2018.10.017DOI Listing
November 2019

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

N Engl J Med 2018 12 20;379(23):2209-2219. Epub 2018 Oct 20.

From Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bichat-Claude Bernard, Departments of Rheumatology (P.-A.J., E.E., S. Ottaviani, P.D.), Genetics (C.K., C. Boileau), Pulmonology A (R.B., B.C.), Pulmonology B (G.T.), and Radiology (M.-P.D.), Département Hospitalo-Universitaire Fibrose Inflammation Remodelage, INSERM Unité Mixte de Recherche (UMR) 1152, Université Paris Diderot (P.-A.J., C.K., R.B., G.T., B.C., P.D.), Arthritis Recherche et Développement (P.-A.J.), AP-HP, Hôpital Lariboisière, Service de Rhumatologie (A. Frazier, P.R.), INSERM, UMR 1132 (P.R.), AP-HP, Hôpital Cochin, Service de Rhumatologie A, and INSERM, Unité 1016, UMR 8104 (Y.A.), AP-HP, Hôpital Tenon, Service de Pneumologie (H.L.), AP-HP, Service de Pneumologie Pédiatrique et Centre de Référence des Maladies Respiratoires Rares, and INSERM UMR S933 (N.N., S.A., A.C.), and AP-HP, Département de Génétique, Hôpital Trousseau (S.A.), Paris, Centre Hospitalier Régional Universitaire (CHRU) de Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Compétence des Maladies Pulmonaires Rares, Fédératif Hospitalo-Universitaire Immune-Mediated Inflammatory Diseases and Targeted Therapies (L.W.-S., B.W.), and Centre Hospitalier Universitaire (CHU) de Lille, Service de Rhumatologie (R.-M.F.), Lille, the Departments of Pulmonology (H.N., D.V.) and Rheumatology (N.S.-K., M.-C.B.), Hôpital Avicenne, AP-HP, INSERM UMR 1125 (N.S.-K., M.-C.B.), and Université Paris 13, Sorbonne Paris Cité (N.S.-K., M.-C.B.), Bobigny, the Department of Pulmonology, CHRU Tours, Tours (S.M.-A.), CHRU de Strasbourg, Service de Rhumatologie, Hôpital de Hautepierre, INSERM UMR S1109, and Laboratoire d'Immuno-Rhumatologie Moléculaire, Centre de Recherche en Histoire des Idées, Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg, Strasbourg (J. Sibilia), Service de Pneumologie (C.D.) and Service de Rhumatologie (C.R., T.S.), CHU de Bordeaux, and ImmunoConcEpT, Centre National de la Recherche Scientifique UMR 5164 (C.R., T.S.), Bordeaux, CHU Clermont-Ferrand, Service de Rhumatologie, Institut National de la Recherche Agronomique (INRA), UMR 1019, Unité de Nutrition Humaine, Centre de Recherche en Nutrition Humaine Auvergne, Clermont-Ferrand (M.S.), and Hospices Civils de Lyon, Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, and INRA, UMR 754, Université Claude Bernard Lyon 1, Lyon, (V.C.) - all in France; the Departments of Medicine (J.S.L., E.D., K.D., A.D.W., A. Fischer, M.I.S., M.H., D.A.S.) and Immunology and Microbiology (D.A.S.), University of Colorado School of Medicine, Aurora, and the Departments of Biomedical Research (T.F.) and Medicine (J.J. Solomon), National Jewish Health, Denver - both in Colorado; the Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba (H.F., S. Oka, N.T.), and the Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara (H.F., S. Oka, S.T.) - both in Japan; the Department of Epidemiology, Harvard T.H. Chan School of Public Health (S.G.), and the Department of Medicine, Brigham and Women's Hospital (T.D., I.O.R.), Boston, and the Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge (S.G.) - all in Massachusetts; the Interstitial Lung Disease and Rheumatology Unit (J.R.-S., M.I.G.-P., M.M., I.B.-R.) and the HLA Laboratory (R.F.-V., E.A.-O.), Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City; the 2nd Pulmonary Medicine Department (E.M., S.A.P.) and the Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine (T.K., D.B.), University Hospital of Athens "Attikon," National and Kapodistrian University of Athens, Athens, and the Department of Respiratory Medicine and the Laboratory of Molecular and Cellular Pneumonology, Faculty of Medicine, University of Crete, Crete (K.A.) - both in Greece; St. Antonius ILD Center of Excellence, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands (C.H.M.M., J.V., Y.A.M., J.C.G.); the Department of Medical Genetics, Nanjing University School of Medicine, Nanjing, China (Y.W.); the Divisions of Pulmonary and Critical Care Medicine (J.H.R.) and Rheumatology (E.L.M.), Mayo Clinic College of Medicine and Science, Rochester, MN; the Colton Center for Autoimmunity, New York University School of Medicine, New York (T.B.N.); the Department of Medicine, McGill University, Montreal (D.A.); the Department of Medicine, University of California, San Francisco, San Francisco (A.G., P.W.); and Data Tecnica International, Glen Echo, and the Laboratory of Neurogenetics, National Institute on Aging, Bethesda - both in Maryland (C. Blauwendraat, M.A.N.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1801562
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1801562DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371965PMC
December 2018

Lung Biopsy in Interstitial Lung Diseases: There Is More than One Way to Cook an Egg.

Respiration 2018 9;96(5):403-405. Epub 2018 Oct 9.

Department of Respiratory Medicine, National Reference Center for Rare Pulmonary Diseases, Hospices Civils de Lyon, Lyon, France.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/493157
Publisher Site
http://dx.doi.org/10.1159/000493157DOI Listing
September 2019

Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration.

Sci Rep 2018 10 2;8(1):14698. Epub 2018 Oct 2.

Université de Lyon, Université Claude Bernard Lyon 1, INRA, EPHE, IVPC, Viral Infections and Comparative Pathology, UMR754, F69007, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-32795-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168484PMC
October 2018